Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer
Roy Z. Granit,
Hadas Masury,
Reba Condiotti,
Yaakov Fixler,
Yael Gabai,
Tzofia Glikman,
Simona Dalin,
Eitan Winter,
Yuval Nevo,
Einat Carmon,
Tamar Sella,
Amir Sonnenblick,
Tamar Peretz,
Ulrich Lehmann,
Keren Paz,
Federica Piccioni,
Aviv Regev,
David E. Root,
Ittai Ben-Porath
Affiliations
Roy Z. Granit
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Hadas Masury
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Reba Condiotti
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Yaakov Fixler
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Yael Gabai
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Tzofia Glikman
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Simona Dalin
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel
Eitan Winter
Info-CORE, Bioinformatics Unit of the I-CORE Computation Center at The Hebrew University and Hadassah, Jerusalem 91120, Israel
Yuval Nevo
Info-CORE, Bioinformatics Unit of the I-CORE Computation Center at The Hebrew University and Hadassah, Jerusalem 91120, Israel
Einat Carmon
Department of Surgery, Hadassah–Hebrew University Medical Center, Jerusalem 91120, Israel
Tamar Sella
Department of Radiology, Hadassah–Hebrew University Medical Center, Jerusalem 91120, Israel
Amir Sonnenblick
Sharett Institute of Oncology, Hadassah–Hebrew University Medical Center, Jerusalem 91120, Israel
Tamar Peretz
Sharett Institute of Oncology, Hadassah–Hebrew University Medical Center, Jerusalem 91120, Israel
Ulrich Lehmann
Institute of Pathology, Medizinische Hochschule Hannover, 30625 Hannover, Germany
Keren Paz
Champions Oncology, Inc., Baltimore, MD 21205, USA
Federica Piccioni
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Aviv Regev
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Howard Hughes Medical Institute and David H. Koch Institute of Integrative Cancer Biology, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
David E. Root
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Ittai Ben-Porath
Department of Developmental Biology and Cancer Research, Institute for Medical Research–Israel-Canada, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel; Corresponding author
Summary: Differentiation events contribute to phenotypic cellular heterogeneity within tumors and influence disease progression and response to therapy. Here, we dissect mechanisms controlling intratumoral heterogeneity within triple-negative basal-like breast cancers. Tumor cells expressing the cytokeratin K14 possess a differentiation state that is associated with that of normal luminal progenitors, and K14-negative cells are in a state closer to that of mature luminal cells. We show that cells can transition between these states through asymmetric divisions, which produce one K14+ and one K14− daughter cell, and that these asymmetric divisions contribute to the generation of cellular heterogeneity. We identified several regulators that control the proportion of K14+ cells in the population. EZH2 and Notch increase the numbers of K14+ cells and their rates of symmetric divisions, and FOXA1 has an opposing effect. Our findings demonstrate that asymmetric divisions generate differentiation transitions and heterogeneity, and identify pathways that control breast cancer cellular composition. : Granit et al. study the sources of phenotypic cellular heterogeneity in triple-negative breast cancers. They find that cancer cells can undergo asymmetric divisions that produce K14+ and K14− daughters and thereby generate heterogeneity. K14+ cells possess a progenitor-associated, tumorigenic phenotype, and the authors identify regulators that control their relative numbers. Keywords: triple-negative breast cancer, basal-like breast cancer, tumor heterogeneity, asymmetric divisions, mammary progenitor cells, EZH2, Notch, FOXA1, NFIB, KLF5